Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital.

Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, Eum SY, Jeon DS, Kang HS, Kim JH, Kim BJ, Kim DY, Holland SM, Park SK, Cho SN, Barry CE 3rd, Via LE.

Clin Infect Dis. 2008 Jan 1;46(1):42-9. doi: 10.1086/524017.

PMID:
18171212
2.

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ, Lee CH, Shim TS.

Am J Respir Crit Care Med. 2010 Jul 1;182(1):113-9. doi: 10.1164/rccm.200911-1656OC. Epub 2010 Mar 11.

PMID:
20224066
3.

Extensively drug-resistant tuberculosis in the United States, 1993-2007.

Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP.

JAMA. 2008 Nov 12;300(18):2153-60. doi: 10.1001/jama.300.18.2153.

PMID:
19001626
4.

Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.

Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB.

PLoS One. 2013;8(2):e55299. doi: 10.1371/journal.pone.0055299. Epub 2013 Feb 4.

5.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154
6.

Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.

Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E.

Int J Tuberc Lung Dis. 2008 Jan;12(1):99-104.

PMID:
18173885
7.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

8.

Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.

Balaji V, Daley P, Anand AA, Sudarsanam T, Michael JS, Sahni RD, Chordia P, George IA, Thomas K, Ganesh A, John KR, Mathai D.

PLoS One. 2010 Mar 4;5(3):e9527. doi: 10.1371/journal.pone.0009527.

9.

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.

Müller B, Chihota VN, Pillay M, Klopper M, Streicher EM, Coetzee G, Trollip A, Hayes C, Bosman ME, Gey van Pittius NC, Victor TC, Gagneux S, van Helden PD, Warren RM.

PLoS One. 2013 Aug 23;8(8):e70919. doi: 10.1371/journal.pone.0070919. eCollection 2013.

10.

Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.

Yuen CM, Kurbatova EV, Tupasi T, Caoili JC, Van Der Walt M, Kvasnovsky C, Yagui M, Bayona J, Contreras C, Leimane V, Ershova J, Via LE, Kim H, Akksilp S, Kazennyy BY, Volchenkov GV, Jou R, Kliiman K, Demikhova OV, Vasilyeva IA, Dalton T, Cegielski JP.

PLoS Med. 2015 Dec 29;12(12):e1001932. doi: 10.1371/journal.pmed.1001932. eCollection 2015 Dec.

11.

Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.

Ndjeka N, Conradie F, Schnippel K, Hughes J, Bantubani N, Ferreira H, Maartens G, Mametja D, Meintjes G, Padanilam X, Variava E, Pym A, Pillay Y.

Int J Tuberc Lung Dis. 2015 Aug;19(8):979-85. doi: 10.5588/ijtld.14.0944.

PMID:
26162365
12.

Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.

Padayatchi N, Gopal M, Naidoo R, Werner L, Naidoo K, Master I, O'Donnell MR.

J Antimicrob Chemother. 2014 Nov;69(11):3103-7. doi: 10.1093/jac/dku235. Epub 2014 Jun 30.

13.

Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.

Moodley P, Shah NS, Tayob N, Connolly C, Zetola N, Gandhi N, Friedland G, Sturm AW.

PLoS One. 2011;6(5):e17513. doi: 10.1371/journal.pone.0017513. Epub 2011 May 31.

14.

Extensively drug-resistant tuberculosis in california, 1993-2006.

Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.

Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

PMID:
18616396
15.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

16.

Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.

Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1228-33. doi: 10.5588/ijtld.12.0037. Epub 2012 Jun 28.

PMID:
22748131
17.

Multidrug- and extensively drug-resistant tuberculosis, Germany.

Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group.

Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729.

18.

Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis.

Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ, Lee CH, Kim JY, Shim TS.

Am J Respir Crit Care Med. 2008 Nov 15;178(10):1075-82. doi: 10.1164/rccm.200801-132OC. Epub 2008 Aug 14.

PMID:
18703792
19.

Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis.

Jeon DS, Kim DH, Kang HS, Hwang SH, Min JH, Kim JH, Sung NM, Carroll MW, Park SK.

Int J Tuberc Lung Dis. 2009 May;13(5):594-600.

PMID:
19383192
20.

Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.

Sharma SK, George N, Kadhiravan T, Saha PK, Mishra HK, Hanif M.

Indian J Med Res. 2009 Oct;130(4):392-5.

PMID:
19942741

Supplemental Content

Support Center